Physician profile
Scott J Raffa
NPI 1770872467
$134,284.32
in general payments reported to CMS, 2019-2025
27 companies · $18K in 2025
The $18K reported for 2025 was more than what 89% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95K · 2020: $65.57 · 2021: $3,564 · 2022: $1,429 · 2023: $3,882 · 2024: $12K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $3,150 · Travel and Lodging: $2,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,712.50 |
| Food and Beverage | $3,150.04 |
| Travel and Lodging | $2,892.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $92,674.19 | 2019 | |
| Globus Medical, INC. | $30,829.72 | 2021-2025 | Elsa, Anthem, Sable |
| Nuvasive, INC. | $3,686.92 | 2019-2023 | Alif, Xlif |
| Medical Device Business Services, INC. | $2,318.16 | 2019-2023 | |
| Depuy Synthes Sales INC. | $1,757.41 | 2021-2024 | Conduit, Viper, Skyline |
| Bioventus LLC | $690.41 | 2024 | Nexus-10 Mkii, Bonescalpel & Sonicone (O.R.) |
| Stryker Corporation | $525.93 | 2019-2023 | Direct Inject, Duramatrix, Adherus Autospray Dural Sealant |
| Carlsmed, INC. | $245.03 | 2022-2023 | Aprevo |
| Spineology INC. | $212.93 | 2019-2021 | |
| Medtronic USA, INC. | $165.77 | 2019 | |
| Medtronic, INC. | $160.44 | 2021-2023 | Unid_pass |
| Boston Scientific Corporation | $136.58 | 2024 | Intracept |
| Nevro Corp. | $132.87 | 2023 | Senza |
| Curonix LLC | $126.28 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cerapedics INC. | $118.07 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $89.93 | 2024 | |
| Zimmer Biomet Holdings, INC. | $83.14 | 2019 | |
| Orthofix Medical, INC. | $76.11 | 2023-2024 | Spinal-Stim, Spinal-Stim, Cervical-Stim |
| Seaspine Orthopedics Corporation | $65.57 | 2020 | |
| Mml US, INC. | $61.11 | 2023 | Reactiv8 |
| Vericel Corporation | $25.02 | 2023 | Maci |
| Integrity Implants INC. | $19.57 | 2019 | |
| Spinal Elements, INC. | $19.49 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.77 | 2022 | |
| Spr Therapeutics, INC | $16.08 | 2023 | Sprint Pns System |
| Zimvie INC. | $15.77 | 2023 | |
| Vertos Medical, INC. | $14.05 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Raffa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.